Veracyte Inc (VCYT)
19.27
+0.07
(+0.36%)
USD |
NASDAQ |
Apr 19, 10:57
Veracyte Total Liabilities (Quarterly): 70.80M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 70.80M |
| September 30, 2023 | 70.88M |
| June 30, 2023 | 78.40M |
| March 31, 2023 | 75.86M |
| December 31, 2022 | 81.22M |
| September 30, 2022 | 77.78M |
| June 30, 2022 | 80.05M |
| March 31, 2022 | 88.40M |
| December 31, 2021 | 91.31M |
| September 30, 2021 | 79.28M |
| June 30, 2021 | 56.26M |
| March 31, 2021 | 50.90M |
| December 31, 2020 | 35.93M |
| September 30, 2020 | 31.43M |
| June 30, 2020 | 30.59M |
| March 31, 2020 | 36.68M |
| December 31, 2019 | 35.76M |
| September 30, 2019 | 29.28M |
| June 30, 2019 | 28.14M |
| March 31, 2019 | 39.76M |
| December 31, 2018 | 40.88M |
| September 30, 2018 | 39.66M |
| Date | Value |
|---|---|
| June 30, 2018 | 39.66M |
| March 31, 2018 | 41.18M |
| December 31, 2017 | 41.44M |
| September 30, 2017 | 40.84M |
| June 30, 2017 | 40.50M |
| March 31, 2017 | 39.26M |
| December 31, 2016 | 41.45M |
| September 30, 2016 | 39.64M |
| June 30, 2016 | 41.08M |
| March 31, 2016 | 40.96M |
| December 31, 2015 | 24.00M |
| September 30, 2015 | 23.04M |
| June 30, 2015 | 17.42M |
| March 31, 2015 | 19.98M |
| December 31, 2014 | 23.46M |
| September 30, 2014 | 23.53M |
| June 30, 2014 | 22.72M |
| March 31, 2014 | 22.16M |
| December 31, 2013 | 23.19M |
| September 30, 2013 | 21.12M |
| June 30, 2013 | 18.75M |
| December 31, 2012 | 14.17M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
28.14M
Minimum
Jun 2019
91.31M
Maximum
Dec 2021
59.42M
Average
70.80M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| Fonar Corp | 45.96M |
| XWELL Inc | 18.02M |
| ProPhase Labs Inc | 42.54M |
| Applied DNA Sciences Inc | 5.785M |
| OncoCyte Corp | 54.42M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.115B |
| Shareholders Equity (Quarterly) | 1.044B |
| Current Ratio | 4.664 |
| Net Debt Paydown Yield | 0.01% |